European Journal of Translational Myology,
Год журнала:
2023,
Номер
unknown
Опубликована: Дек. 18, 2023
At
the
end
of
2023
Padua
Days
Muscle
and
Mobility
Medicine
next
year's
meeting
was
scheduled
from
27
February
to
2
March
2024
(2024Pdm3).
During
summer
autumn
program
confirmed
with
Scientific
Sessions
that
will
take
place
over
five
days,
starting
in
afternoon
27,
at
Conference
Room
Hotel
Petrarca,
Thermae
Euganean
Hills
(Padua),
Italy.
As
usual,
day
be
spent
Padua,
this
occasion
San
Luca
Hall
Santa
Giustina
monastery
Prato
della
Valle,
Collected
during
Autumn
2023,
many
more
titles
abstracts
than
expected
were
submitted,
forcing
organization
parallel
sessions
both
on
1
confirming
attractiveness
Pdm3.
The
days
include
oral
presentations
scientists
clinicians
Argentina,
Austria,
Belgium,
Brazil,
Canada,
Denmark,
Egypt,
France,
Germany,
Iceland,
Ireland,
Italy,
Romania,
Russia,
Slovenia,
Switzerland,
UK
USA.
Together
preliminary
Program
December
1,
early
submitted
Abstracts
is
e-published
Issue
33
(4)
European
Journal
Translational
Myology
(EJTM).
You
are
invited
join,
submitting
your
Last
Minute
[email protected]
by
2024.
Furthermore,
generous
deadline
May
20,
2024,
submit
please
“Communications”
(Clarivate’s
ESCI
Impact
factor
2.2;
SCOPUS
Cite
Score:
3.2).
See
you
soon
Petrarca
Montegrotto
Terme,
but
complete
can
followed
home
via
zoom
connection.
Advanced Science,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 31, 2025
Abstract
While
mitochondria
are
known
to
be
essential
for
intracellular
energy
production
and
overall
function,
emerging
evidence
highlights
their
role
in
influencing
cell
behavior
through
mitochondrial
transfer.
This
phenomenon
provides
a
potential
basis
the
development
of
treatment
strategies
tissue
damage
degeneration.
study
aims
evaluate
whether
isolated
from
osteoblasts
can
promote
osteogenic
differentiation
mesenchymal
stem
cells
(MSCs).
Mitochondria
MSCs,
which
primarily
utilize
glycolysis,
compared
with
those
MG63
cells,
depend
on
oxidative
phosphorylation.
both
types
then
encapsulated
cationic
liposomes
transferred
impact
is
assessed.
delivery
MSCs
grown
two‐
three‐dimensional
cultures
results
increased
expression
markers,
including
Runt‐related
transcription
factor
2,
Osterix,
Osteopontin,
upregulation
genes
involved
Bone
morphogenetic
protein
2
signaling
calcium
import.
accompanied
by
influx
regulated
Wnt/β‐catenin
pathway.
Transplantation
spheroids
containing
MG63‐derived
bone
defect
animal
models
improves
regeneration.
The
suggest
that
effectively
guides
toward
osteogenesis,
paving
way
mitochondria‐transplantation
therapies.
Journal of Cerebral Blood Flow & Metabolism,
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 14, 2024
In
the
central
nervous
system
(CNS),
neuronal
function
and
dysfunction
are
critically
dependent
on
mitochondrial
integrity
activity.
damaged
or
diseased
brains,
reduces
adenosine
triphosphate
(ATP)
levels
impairs
ATP-dependent
neural
firing
neurotransmitter
dynamics.
Restoring
capacity
to
generate
ATP
may
be
fundamental
in
restoring
function.
Recent
studies
animals
humans
have
demonstrated
that
endogenous
mitochondria
released
into
extracellular
environment
transported
exchanged
between
cells
CNS.
Under
pathological
conditions
CNS,
intercellular
transfer
contributes
new
classes
of
signaling
multifunctional
cellular
activities,
thereby
triggering
deleterious
effects
promoting
beneficial
responses.
Therefore,
take
full
advantage
mitochondria,
it
useful
transplant
healthy
viable
tissues.
this
review,
we
describe
recent
findings
mechanisms
provide
an
overview
experimental
methodologies,
including
tissue
sourcing,
isolation,
storage,
modification,
aimed
at
optimizing
transplantation
therapy
for
CNS
disorders.
Additionally,
examine
clinical
relevance
potential
strategies
therapeutic
application
transplantation.
AJP Cell Physiology,
Год журнала:
2023,
Номер
326(2), С. C449 - C456
Опубликована: Дек. 25, 2023
Ischemia-reperfusion
(IR)
is
known
to
induce
severe
tissue
damage,
notably
through
mitochondrial
dysfunction.
Mitochondrial
transplantation
has
emerged
as
a
promising
therapeutic
strategy
in
cardiac
IR;
however,
few
studies
have
previously
assessed
its
efficacy
the
context
of
peripheral
IR.
Therefore,
objective
this
study
was
assess
effect
hindlimb
model
IR
injury.
Thirty-six
SWISS
mice
were
divided
into
three
groups:
control
(CTL,
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Сен. 23, 2024
Abstract
Mitochondria,
known
as
the
powerhouse
of
cell,
are
essential
for
cellular
energy
production.
Dysfunction
in
mitochondrial
function
can
significantly
affect
various
organs.
Transplanting
healthy
mitochondria
enhance
bioenergetics
diseased
cells
and
treat
conditions,
yet
limits
transplantation
still
unknown.
Our
study
reveals
that
source
transplanted
is
not
restricted
by
species,
recipient
show
no
significant
immune
response
to
from
different
lineages.
We
also
found
metabolic
compatibility
between
exogenous
crucial,
transplanting
species
endow
with
distinct
characteristics
combat
diseases.
Furthermore,
our
data
indicate
there
competition
among
varying
functions,
more
powerful
yielding
better
therapeutic
effects.
Notably,
we
have
an
upper
limit
bio-enhancement
provided
mitochondria.
research
proposes
a
feasible
path
human
through
transplantation—adaptive
bio-enhancement.
Mitochondrial
highly
clinically
valuable
technique.
I
further
expanded
variety
sources
demonstrated
potential
adaptively
biological
functions.
European Journal of Translational Myology,
Год журнала:
2023,
Номер
unknown
Опубликована: Дек. 18, 2023
At
the
end
of
2023
Padua
Days
Muscle
and
Mobility
Medicine
next
year's
meeting
was
scheduled
from
27
February
to
2
March
2024
(2024Pdm3).
During
summer
autumn
program
confirmed
with
Scientific
Sessions
that
will
take
place
over
five
days,
starting
in
afternoon
27,
at
Conference
Room
Hotel
Petrarca,
Thermae
Euganean
Hills
(Padua),
Italy.
As
usual,
day
be
spent
Padua,
this
occasion
San
Luca
Hall
Santa
Giustina
monastery
Prato
della
Valle,
Collected
during
Autumn
2023,
many
more
titles
abstracts
than
expected
were
submitted,
forcing
organization
parallel
sessions
both
on
1
confirming
attractiveness
Pdm3.
The
days
include
oral
presentations
scientists
clinicians
Argentina,
Austria,
Belgium,
Brazil,
Canada,
Denmark,
Egypt,
France,
Germany,
Iceland,
Ireland,
Italy,
Romania,
Russia,
Slovenia,
Switzerland,
UK
USA.
Together
preliminary
Program
December
1,
early
submitted
Abstracts
is
e-published
Issue
33
(4)
European
Journal
Translational
Myology
(EJTM).
You
are
invited
join,
submitting
your
Last
Minute
[email protected]
by
2024.
Furthermore,
generous
deadline
May
20,
2024,
submit
please
“Communications”
(Clarivate’s
ESCI
Impact
factor
2.2;
SCOPUS
Cite
Score:
3.2).
See
you
soon
Petrarca
Montegrotto
Terme,
but
complete
can
followed
home
via
zoom
connection.